A detailed history of Carnegie Capital Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 5,620 shares of EW stock, worth $518,838. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,620
Previous 6,370 11.77%
Holding current value
$518,838
Previous $485,000 10.72%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $54,405 - $71,670
-750 Reduced 11.77%
5,620 $537,000
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $43,258 - $54,509
701 Added 12.37%
6,370 $485,000
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $20,352 - $23,582
-250 Reduced 4.22%
5,669 $534,000
Q1 2023

Apr 19, 2023

SELL
$74.26 - $84.51 $1,039 - $1,183
-14 Reduced 0.24%
5,919 $489,000
Q4 2022

Jan 23, 2023

BUY
$68.3 - $87.44 $956 - $1,224
14 Added 0.24%
5,933 $0
Q3 2022

Oct 13, 2022

SELL
$82.37 - $107.29 $49,422 - $64,374
-600 Reduced 9.2%
5,919 $489,000
Q2 2022

Aug 02, 2022

SELL
$86.5 - $128.27 $120,235 - $178,295
-1,390 Reduced 17.57%
6,519 $620,000
Q2 2022

Jul 13, 2022

BUY
$86.5 - $128.27 $684,128 - $1.01 Million
7,909 New
7,909 $819,000
Q1 2022

Apr 11, 2022

SELL
$101.96 - $128.34 $735,029 - $925,203
-7,209 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$106.37 - $130.68 $127,644 - $156,816
-1,200 Reduced 14.27%
7,209 $934,000
Q3 2021

Oct 08, 2021

BUY
$102.91 - $122.75 $51,455 - $61,375
500 Added 6.32%
8,409 $952,000
Q2 2021

Jul 16, 2021

SELL
$83.84 - $104.76 $6,288 - $7,857
-75 Reduced 0.94%
7,909 $819,000
Q1 2021

Apr 12, 2021

BUY
$78.68 - $90.67 $173,096 - $199,474
2,200 Added 38.04%
7,984 $668,000
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $50,111 - $63,769
699 Added 13.75%
5,784 $528,000
Q2 2020

Jul 09, 2020

BUY
$57.54 - $76.95 $195,060 - $260,860
3,390 Added 200.0%
5,085 $351,000
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $8,018 - $12,393
-153 Reduced 8.28%
1,695 $320,000
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $5,449 - $6,238
-76 Reduced 3.95%
1,848 $431,000
Q3 2019

Nov 20, 2019

SELL
$61.55 - $75.43 $7,386 - $9,051
-120 Reduced 5.87%
1,924 $423,000
Q2 2019

Jul 24, 2019

BUY
$55.74 - $64.41 $9,364 - $10,820
168 Added 8.96%
2,044 $378,000
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $89,841 - $120,157
1,876 New
1,876 $359,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.